EXHIBIT 99.1
For More Information:
Investor contact: Aaron Pearce 414-438-6895
Media contact: Carole Herbstreit 414-438-6882
For Immediate Release
Brady Corporation Reports Fiscal 2013 First Quarter Results
MILWAUKEE (November 15, 2012)—Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for the fiscal 2013 first quarter ended October 31, 2012.
Quarter Ended October 31, 2012 Financial Results:
Sales for the fiscal 2013 first quarter ended October 31, 2012, were down 3.4 percent to $337.6 million compared to $349.5 million in the first quarter of fiscal 2012. Organic sales were down 1.9 percent, the impact of foreign currency translation decreased sales by 2.1 percent, and acquisitions, net of divestitures added 0.6 percent. By segment, organic sales decreased 0.7 percent in the Americas, 3.2 percent in EMEA and 2.5 percent in the Asia-Pacific region.
Net income in the fiscal 2013 first quarter was down 16.9 percent to $27.2 million compared to $32.7 million in the same quarter last year. Excluding the losses in the first quarter of fiscal 2013 from the sales of Brady Medical, a medical die-cut business headquartered in Texas, and Varitronics, a business headquartered in Minnesota serving the education market, net income was down 7.1 percent to $30.4 million.
Earnings per diluted Class A Common Share were down 14.5 percent to $0.53 in the first quarter of fiscal 2013 compared to $0.62 in the same quarter last year. Diluted Earnings per Class A Common Share excluding losses on the sales of businesses were down 4.8 percent to $0.59 in the first quarter of fiscal 2013.
Commentary and Guidance:
“I am pleased with our performance in the quarter as our business in the Americas and Asia-Pacific showed improved results over last quarter. In Asia in particular we benefited from several new product wins in the mobile handset and tablet computer space,” said Brady’s President and Chief Executive Officer, Frank M. Jaehnert. “Europe continues to be impacted by a difficult economic environment, and we are shifting resources to higher growth opportunities in Central Europe, the Middle East, and Africa. In addition, we are continuing to prune our portfolio of businesses. As we look to the remainder of fiscal 2013, we believe there is limited likelihood that the macro-economy will provide a tailwind. We therefore will continue on the path to create our own growth story by further investing in geographic expansion; expanding globally in certain focus markets, such as aerospace and mass transit, chemical, oil and gas, and food and beverage processing; new product development; customer conversion; and expansion of our digital capabilities to provide the best overall buying experience for our customers.”
“We anticipate approximately flat organic sales growth for the full fiscal year 2013, with sales growth in the second half of the year driven by our initiatives,” said Brady’s Chief Financial Officer Thomas J. Felmer. “We are reiterating our full-year fiscal 2013 earnings per diluted Class A Common Share guidance of between $2.20 and $2.40, exclusive of after-tax restructuring charges and gains or losses on the sales of any businesses. This guidance is based on exchange rates as of October 31, 2012, and a full-year income tax rate in the mid-to-upper 20 percent range.”
A webcast regarding Brady’s fiscal 2013 first quarter financial results will be available atwww.bradycorp.com beginning at 9:30 a.m. Central Time today.
Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect premises, products and people. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels and signs, safety devices, printing systems and software, and precision die-cut materials. Founded in 1914, the company has millions of customers in electronics, telecommunications, manufacturing, electrical, construction, education, medical and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2012 employed approximately 6,900 people at operations in the Americas, EMEA and Asia-Pacific. Brady’s fiscal 2012 sales were approximately $1.32 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet atwww.bradycorp.com.
###
In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company’s future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: the length or severity of the current worldwide economic downturn or timing or strength of a subsequent recovery; increased usage of e-commerce allowing for ease of price transparency; future financial performance of major markets Brady serves, which include, without limitation, telecommunications, hard disk drive, manufacturing, electrical, construction, laboratory, education, governmental, public utility, computer, and transportation; future competition; changes in the supply of, or price for, parts and components; increased price pressure from suppliers and customers; Brady’s ability to retain significant contracts and customers; fluctuations in currency rates versus the U.S. dollar; risks associated with international operations; difficulties associated with exports; risks associated with obtaining governmental approvals and maintaining regulatory compliance; Brady’s ability to develop and successfully market new products; difficulties in making and integrating acquisitions; risks associated with newly acquired businesses; risks associated with restructuring plans; environmental, health and safety compliance costs and liabilities; technology changes and potential security violations to the Company’s information technology systems; Brady’s ability to maintain compliance with its debt covenants; increase in our level of debt; potential write-offs of Brady’s substantial intangible assets; unforeseen tax consequences; and numerous other matters of national, regional and global scale, including those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2012.
These uncertainties may cause Brady’s actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in Thousands, Except Per Share Amounts)
(Unaudited) | ||||||||
Three Months Ended October 31, | ||||||||
2012 | 2011 | |||||||
Net sales | $ | 337,646 | $ | 349,508 | ||||
Cost of products sold | 173,026 | 181,677 | ||||||
|
|
|
| |||||
Gross margin | 164,620 | 167,831 | ||||||
Operating expenses: | ||||||||
Research and development | 8,485 | 9,809 | ||||||
Selling, general and administrative | 108,261 | 108,932 | ||||||
Loss (gain) on sales of businesses | 3,438 | — | ||||||
|
|
|
| |||||
Total operating expenses | 120,184 | 118,741 | ||||||
Operating income | 44,436 | 49,090 | ||||||
Other income and (expense): | ||||||||
Investment and other income (expense) | 397 | (202 | ) | |||||
Interest expense | (4,163 | ) | (5,047 | ) | ||||
|
|
|
| |||||
Income before income taxes | 40,670 | 43,841 | ||||||
Income taxes | 13,482 | 11,109 | ||||||
|
|
|
| |||||
Net income | $ | 27,188 | $ | 32,732 | ||||
|
|
|
| |||||
Per Class A Nonvoting Common Share: | ||||||||
Basic net income | $ | 0.53 | $ | 0.62 | ||||
Diluted net income | $ | 0.53 | $ | 0.62 | ||||
Dividends | $ | 0.19 | $ | 0.185 | ||||
Per Class B Voting Common Share: | ||||||||
Basic net income | $ | 0.52 | $ | 0.60 | ||||
Diluted net income | $ | 0.51 | $ | 0.60 | ||||
Dividends | $ | 0.173 | $ | 0.168 | ||||
Weighted average common shares outstanding (in thousands): | ||||||||
Basic | 51,039 | 52,657 | ||||||
Diluted | 51,312 | 52,954 |
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)
(Unaudited) | ||||||||
October 31, 2012 | July 31, 2012 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 321,309 | $ | 305,900 | ||||
Accounts receivable—net | 218,246 | 199,006 | ||||||
Inventories: | ||||||||
Finished products | 67,992 | 64,740 | ||||||
Work-in-process | 16,280 | 15,377 | ||||||
Raw materials and supplies | 26,255 | 25,407 | ||||||
|
|
|
| |||||
Total inventories | 110,527 | 105,524 | ||||||
Prepaid expenses and other current assets | 42,400 | 40,424 | ||||||
|
|
|
| |||||
Total current assets | 692,482 | 650,854 | ||||||
Other assets: | ||||||||
Goodwill | 680,595 | 676,791 | ||||||
Other intangible assets | 80,983 | 84,119 | ||||||
Deferred income taxes | 46,627 | 45,356 | ||||||
Other | 21,577 | 20,584 | ||||||
Property, plant and equipment: | ||||||||
Cost: | ||||||||
Land | 8,892 | 8,651 | ||||||
Buildings and improvements | 102,592 | 101,962 | ||||||
Machinery and equipment | 296,561 | 292,130 | ||||||
Construction in progress | 10,064 | 10,417 | ||||||
|
|
|
| |||||
418,109 | 413,160 | |||||||
Less accumulated depreciation | 288,949 | 283,145 | ||||||
|
|
|
| |||||
Property, plant and equipment—net | 129,160 | 130,015 | ||||||
|
|
|
| |||||
Total | $ | 1,651,424 | $ | 1,607,719 | ||||
|
|
|
| |||||
LIABILITIES AND STOCKHOLDERS’ INVESTMENT | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 105,348 | $ | 86,646 | ||||
Wages and amounts withheld from employees | 40,529 | 54,629 | ||||||
Taxes, other than income taxes | 8,211 | 9,307 | ||||||
Accrued income taxes | 12,153 | 14,357 | ||||||
Other current liabilities | 44,686 | 40,815 | ||||||
Current maturities on long-term debt | 61,264 | 61,264 | ||||||
|
|
|
| |||||
Total current liabilities | 272,191 | 267,018 | ||||||
Long-term obligations, less current maturities | 259,729 | 254,944 | ||||||
Other liabilities | 78,538 | 76,404 | ||||||
|
|
|
| |||||
Total liabilities | 610,458 | 598,366 | ||||||
Stockholders’ investment: | ||||||||
Common stock: | ||||||||
Class A nonvoting common stock—Issued 51,261,487 and 51,261,487 shares, respectively and outstanding 47,563,704 and 47,630,926 shares, respectively | 513 | 513 | ||||||
Class B voting common stock—Issued and outstanding, 3,538,628 shares | 35 | 35 | ||||||
Additional paid-in capital | 314,896 | 313,008 | ||||||
Earnings retained in the business | 749,773 | 732,290 | ||||||
Treasury stock—3,387,783 and 3,245,561 shares, respectively of Class A nonvoting common stock, at cost | (93,535 | ) | (92,600 | ) | ||||
Accumulated other comprehensive income | 72,178 | 59,411 | ||||||
Other | (2,894 | ) | (3,304 | ) | ||||
|
|
|
| |||||
Total stockholders’ investment | 1,040,966 | 1,009,353 | ||||||
|
|
|
| |||||
Total | $ | 1,651,424 | $ | 1,607,719 | ||||
|
|
|
|
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)
(Unaudited) | ||||||||
Three Months Ended | ||||||||
October 31, | ||||||||
2012 | 2011 | |||||||
Operating activities: | ||||||||
Net income | $ | 27,188 | $ | 32,732 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 10,675 | 11,241 | ||||||
Deferred income taxes | (109 | ) | 4,399 | |||||
Non-cash portion of stock-based compensation expense | 4,399 | 3,591 | ||||||
Loss (gain) on sales of businesses | 3,138 | — | ||||||
Changes in operating assets and liabilities | ||||||||
Accounts receivable | (18,426 | ) | (7,798 | ) | ||||
Inventories | (8,141 | ) | (7,156 | ) | ||||
Prepaid expenses and other assets | (2,710 | ) | (7,384 | ) | ||||
Accounts payable and accrued liabilities | 6,752 | (21,814 | ) | |||||
Income taxes | (2,548 | ) | 7,470 | |||||
|
|
|
| |||||
Net cash provided by operating activities | 20,218 | 15,281 | ||||||
Investing activities: | ||||||||
Purchases of property, plant and equipment | (6,177 | ) | (5,817 | ) | ||||
Settlement of net investment hedges | — | (958 | ) | |||||
Sales of businesses, net of cash retained | 10,178 | — | ||||||
Other | (70 | ) | (233 | ) | ||||
|
|
|
| |||||
Net cash provided by (used in) investing activities | 3,931 | (7,008 | ) | |||||
Financing activities: | ||||||||
Payment of dividends | (9,704 | ) | (9,690 | ) | ||||
Proceeds from issuance of common stock | 1,684 | 683 | ||||||
Purchase of treasury stock | (5,121 | ) | (12,309 | ) | ||||
Income tax benefit from the exercise of stock options and deferred compensation distribution, and other | 400 | 456 | ||||||
|
|
|
| |||||
Net cash used in financing activities | (12,741 | ) | (20,860 | ) | ||||
Effect of exchange rate changes on cash | 4,001 | (5,790 | ) | |||||
Net increase (decrease) in cash and cash equivalents | 15,409 | (18,377 | ) | |||||
Cash and cash equivalents, beginning of period | 305,900 | 389,971 | ||||||
|
|
|
| |||||
Cash and cash equivalents, end of period | $ | 321,309 | $ | 371,594 | ||||
|
|
|
| |||||
Supplemental disclosures: | ||||||||
Cash paid during the period for: | ||||||||
Interest, net of capitalized interest | $ | 4,953 | $ | 6,082 | ||||
Income taxes, net of refunds | 12,199 | 5,825 |
Information by regional segment for the three months ended October 31, 2012 and 2011 is as follows:
(in thousands) | Americas | EMEA | Asia-Pacific | Total Region | Corporate and Eliminations | Total | ||||||||||||||||||
SALES TO EXTERNAL CUSTOMERS |
| |||||||||||||||||||||||
Three months ended: | ||||||||||||||||||||||||
October 31, 2012 | $ | 148,692 | $ | 93,233 | $ | 95,721 | $ | 337,646 | — | $ | 337,646 | |||||||||||||
October 31, 2011 | $ | 153,863 | $ | 97,356 | $ | 98,289 | $ | 349,508 | — | $ | 349,508 | |||||||||||||
SALES GROWTH INFORMATION | ||||||||||||||||||||||||
Three months ended October 31, 2012: | ||||||||||||||||||||||||
Base | -0.7 | % | -3.2 | % | -2.5 | % | -1.9 | % | — | -1.9 | % | |||||||||||||
Currency | -1.1 | % | -5.7 | % | -0.1 | % | -2.1 | % | — | -2.1 | % | |||||||||||||
Acquisitions/Divestitures | -1.6 | % | 4.7 | % | 0.0 | % | 0.6 | % | — | 0.6 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total | -3.4 | % | -4.2 | % | -2.6 | % | -3.4 | % | — | -3.4 | % | |||||||||||||
Three months ended October 31, 2011: | ||||||||||||||||||||||||
Base | 5.7 | % | 3.7 | % | -0.2 | % | 3.5 | % | — | 3.5 | % | |||||||||||||
Currency | 0.4 | % | 3.7 | % | 5.5 | % | 2.7 | % | — | 2.7 | % | |||||||||||||
Acquisitions/Divestitures | -0.7 | % | -1.6 | % | 2.1 | % | -0.2 | % | — | -0.2 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total | 5.4 | % | 5.8 | % | 7.4 | % | 6.0 | % | — | 6.0 | % | |||||||||||||
SEGMENT PROFIT (LOSS) | ||||||||||||||||||||||||
Three months ended: | ||||||||||||||||||||||||
October 31, 2012 | $ | 44,633 | $ | 23,567 | $ | 12,055 | $ | 80,255 | $ | (1,973 | ) | $ | 78,282 | |||||||||||
October 31, 2011 | $ | 43,230 | $ | 26,299 | $ | 13,304 | $ | 82,833 | $ | (3,263 | ) | $ | 79,570 | |||||||||||
Percentage increase (decrease) | 3.2 | % | -10.4 | % | -9.4 | % | -3.1 | % | -1.6 | % |
NET INCOME RECONCILIATION (in thousands)
Three months ended: | ||||||||
October 31, 2012 | October 31, 2011 | |||||||
Total profit for reportable segments | $ | 80,255 | $ | 82,833 | ||||
Corporate and eliminations | (1,973 | ) | (3,263 | ) | ||||
Unallocated amounts: | ||||||||
Administrative costs | (30,408 | ) | (30,480 | ) | ||||
Loss (gain) on sales of businesses | (3,438 | ) | — | |||||
Investment and other income (expense) | 397 | (202 | ) | |||||
Interest expense | (4,163 | ) | (5,047 | ) | ||||
|
|
|
| |||||
Income before income taxes | 40,670 | 43,841 | ||||||
Income taxes | (13,482 | ) | (11,109 | ) | ||||
|
|
|
| |||||
Net income | $ | 27,188 | $ | 32,732 | ||||
|
|
|
|
NON-GAAP MEASURES
(Dollars in Thousands, Except Per Share Amounts)
In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.
EBITDA:
Brady is presenting EBITDA because it is used by many of our investors and lenders, and is presented as a convenience to them. EBITDA represents net income before interest expense, income taxes, depreciation and amortization. EBITDA is not a calculation based on generally accepted accounting principles ("GAAP"). The amounts included in the EBITDA calculation, however, are derived from amounts included in the Condensed Consolidated Statements of Income data. EBITDA should not be considered as an alternative to net income or operating income as an indicator of the Company's operating performance, or as an alternative to operating cash flows as a measure of liquidity. The EBITDA measure presented may not always be comparable to similarly titled measures reported by other companies due to differences in the components of the calculation.
Fiscal 2013 | ||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||||||
EBITDA: | ||||||||||||||||||||
Net income | $ | 27,188 | $ | — | $ | — | $ | — | $ | 27,188 | ||||||||||
Interest expense | 4,163 | — | — | — | 4,163 | |||||||||||||||
Income taxes | 13,482 | — | — | — | 13,482 | |||||||||||||||
Depreciation and amortization | 10,675 | — | — | — | 10,675 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
EBITDA (non-GAAP measure) | $ | 55,508 | $ | — | $ | — | $ | — | $ | 55,508 | ||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Fiscal 2012 | ||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||||||||||||
EBITDA: | ||||||||||||||||||||
Net income (loss) | $ | 32,732 | $ | (89,954 | ) | $ | 27,652 | $ | 11,659 | $ | (17,911 | ) | ||||||||
Interest expense | 5,047 | 4,933 | 4,735 | 4,375 | 19,090 | |||||||||||||||
Income taxes | 11,109 | 8,635 | 9,676 | 11,241 | 40,661 | |||||||||||||||
Depreciation and amortization | 11,241 | 10,935 | 10,745 | 11,066 | 43,987 | |||||||||||||||
Impairment charge | — | 115,688 | — | — | 115,688 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
EBITDA (non-GAAP measure) | $ | 60,129 | $ | 50,237 | $ | 52,808 | $ | 38,341 | $ | 201,515 | ||||||||||
|
|
|
|
|
|
|
|
|
|
Diluted Earnings Per Share Excluding Losses on the Sales of Businesses:
This is a measure of the Company’s diluted net earnings per share excluding current year losses on the sales of businesses. We do not view these items to be part of our sustainable results. We believe this earnings per share measure provides an important perspective of underlying business trends and results and provides a more comparable measure of year-on-year earnings per share growth. The table below provides a reconciliation of diluted earnings per share to diluted earnings per share excluding losses on the sales of businesses:
Three Months Ended October 31, | ||||||||
2012 | 2011 | |||||||
Diluted Earnings per Share | $ | 0.53 | $ | 0.62 | ||||
Loss on the sale of Brady Medical | 0.05 | — | ||||||
Loss on the sale of Varitronics | 0.01 | — | ||||||
|
|
|
| |||||
Diluted Earnings per Share Excluding Losses on the Sales of Businesses | $ | 0.59 | $ | 0.62 | ||||
|
|
|
|
All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.
Net Income Excluding Losses on the Sales of Businesses:
This is a measure of the Company’s net income excluding current year losses on the sales of businesses. We do not view these items to be part of our sustainable results. We believe this net income measure provides an important perspective of underlying business trends and results and provides a more comparable measure of year-on-year net income growth. The table below provides a reconciliation of net income to net income excluding the losses on the sales of businesses:
Three Months Ended October 31, | ||||||||
2012 | 2011 | |||||||
Net Income | $ | 27,188 | $ | 32,732 | ||||
Loss on the sale of Brady Medical | 2,577 | — | ||||||
Loss on the sale of Varitronics | 638 | — | ||||||
|
|
|
| |||||
Net Income Excluding Losses on the Sales of Businesses | $ | 30,403 | $ | 32,732 | ||||
|
|
|
|
All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.